Vaxxinity (VAXX) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$0.48

+0.01 (+2.43%)

(As of 05:21 PM ET)

Source

Source	Headline
	Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock globenewswire.com - April 19 at 4:27 PM
	Vaxxinity (NASDAQ:VAXX) Trading 2.1% Higher americanbankingnews.com - April 10 at 2:24 AM
	Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting globenewswire.com - March 28 at 9:23 AM
	VAXX Stock Earnings: Vaxxinity Beats EPS for Q4 2023 investorplace.com - March 27 at 11:03 PM
	Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates globenewswire.com - March 27 at 4:41 PM
	Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024 globenewswire.com - March 7 at 10:32 AM
	Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels finance.yahoo.com - February 15 at 2:41 PM
	Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published finance.yahoo.com - February 15 at 9:40 AM
	Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published globenewswire.com - February 15 at 8:00 AM
	Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 finance.yahoo.com - February 13 at 8:20 AM
	Vaxxinity (NASDAQ:VAXX) Shares Down 2.2% marketbeat.com - February 8 at 2:46 AM
	Vaxxinity, UF Join Forces Against Neurodegenerative Diseases finance.yahoo.com - January 30 at 2:16 PM
	Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida finance.yahoo.com - January 30 at 9:15 AM
	Vaxxinity & UCF to Collaborate on Space Medicine Research finance.yahoo.com - January 19 at 3:05 PM
	Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida finance.yahoo.com - January 18 at 8:33 AM
	Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference finance.yahoo.com - January 3 at 12:34 PM
	The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity finance.yahoo.com - December 12 at 11:22 AM
	Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others markets.businessinsider.com - November 21 at 7:47 PM
	Several Alzheimer's vaccines enter clinical trials amid breakthrough treatments' success foxnews.com - November 20 at 6:32 PM
	Researchers return to Alzheimer's vaccines, buoyed by recent drug success msn.com - November 20 at 8:31 AM
	Vaxxinity to Present at Upcoming November Medical and Investor Conferences finance.yahoo.com - November 13 at 7:50 PM
	Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - November 8 at 9:19 AM
	Private companies invested in Vaxxinity, Inc. (NASDAQ:VAXX) copped the brunt of last week's US$41m market cap decline finance.yahoo.com - October 10 at 4:04 PM
	Movers Lab Fund I. Lp Prime Sells 25,089 Shares of Vaxxinity, Inc. (NASDAQ:VAXX) Stock marketbeat.com - September 8 at 8:27 PM
	Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX) finance.yahoo.com - September 7 at 3:46 PM
	Vaxxinity Says UB-311 Shows Potential Advancements in Alzheimer’s Treatment finance.yahoo.com - August 11 at 3:01 AM
	Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease finance.yahoo.com - August 10 at 10:36 AM
	Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - August 9 at 1:09 PM
	Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director finance.yahoo.com - July 28 at 10:57 AM
	Vaxxinity Appoints Dr. Peter Powchik as Global Scientific Director finance.yahoo.com - July 28 at 10:57 AM
	Lincoln National Corp Invests $93,000 in Vaxxinity, Inc. (NASDAQ:VAXX) marketbeat.com - July 28 at 5:56 AM
	Promising Milestone in Neurodegenerative Disease Treatment: Vaxxinity’s UB-312 in Parkinson’s Patients finance.yahoo.com - July 17 at 3:23 PM
	Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinson’s Patients finance.yahoo.com - July 17 at 10:21 AM
	McAdam LLC Buys New Stake in Vaxxinity, Inc. (NASDAQ:VAXX) marketbeat.com - July 9 at 6:38 AM
	Positive Phase 1 Results: Vaxxinity’s UB-312 Shows Promise in Parkinson’s Disease finance.yahoo.com - June 22 at 3:17 PM
	Vaxxinity Touts Encouraging Data From Early-Stage Parkinson's Vaccine Trial finance.yahoo.com - June 22 at 3:17 PM
	Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease finance.yahoo.com - June 22 at 10:16 AM
	Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - May 9 at 9:26 AM
	Vaxxinity, Inc.'s (NASDAQ:VAXX) biggest owners are private companies who got richer after stock soared 23% last week finance.yahoo.com - May 3 at 8:26 AM
	Weekly Biotech Pulse: Vaxxinity results, Biogen's FDA review, and more \| Pro Recap finance.yahoo.com - April 24 at 8:42 AM
	Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April finance.yahoo.com - March 28 at 12:42 PM
	Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates finance.yahoo.com - March 27 at 10:49 AM
	Vaxxinity Joins TransCelerate Research and Development Consortium finance.yahoo.com - March 21 at 10:17 AM
	Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia finance.yahoo.com - March 20 at 8:07 AM
	Vaxxinity to Present at Upcoming March Scientific and Medical Conferences finance.yahoo.com - March 2 at 9:54 AM
	Nektar Therapeutics (NKTR) was downgraded to a Sell Rating at Jefferies markets.businessinsider.com - February 24 at 5:39 PM
	First Republic Investment Management Inc. Buys New Position in Vaxxinity, Inc. (NASDAQ:VAXX) marketbeat.com - February 9 at 4:43 AM
	Why Shares of Vaxxinity Jumped This Week finance.yahoo.com - January 19 at 5:32 PM
	Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference finance.yahoo.com - January 5 at 8:48 AM
	Estimating The Fair Value Of Vaxxinity, Inc. (NASDAQ:VAXX) finance.yahoo.com - December 31 at 12:18 PM

Get Vaxxinity News Delivered to You Automatically

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

VAXX Media Mentions By Week

VAXX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VAXX
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

VAXX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VAXX Articles
This Week
▼
0

0
▲
VAXX Articles
Average Week

Get Vaxxinity News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:VAXX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vaxxinity (VAXX) News Today

VAXX Media Mentions By Week

VAXX Media Sentiment

VAXX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info